RICOVR Healthcare Announces Successful Human Saliva Testing with XALIVA® THC
Traditional urine and hair-based test methods detect THC metabolites, which indicate past use for 30 days or more. California’s new off-duty use employee protection law bans the use of urine and hair cannabis testing for this reason. With the legalization of recreational marijuana in 19 states and another 37 with legal, medical marijuana, there is a strong need for a test that only detects recent use that better aligns with impairment to maintain workplace safety.
The Company’s technology utilizes a novel plasmonic fiber-optic absorbance biosensor (P-FAB) that only detects recent use (within 8 to 10 hours) and provides fairness to legal users outside of work while ensuring safety on the job. With high accuracy, the XALIVA platform has been shown to provide real-time THC detection using saliva within about fifteen minutes.
The device is a truly portable and cost-effective solution to screen employees at the workplace. RICOVR will expand on the results of this study with more user samples and is also in discussion with leading academic institutions for partnership.
RICOVR Healthcare is the creator of the XALIVA rapid diagnostics platform, which provides high-quality, rapid diagnostics results using a small amount of saliva. The company’s product pipeline includes rapid point-of-care tests for THC, drugs-of-abuse, and infectious diseases. The Company boasts a distinguished advisory board and management team of scientists and engineers committed to positively impacting society. In addition, the company has strong partnerships with leading research institutions and medical device manufacturing companies around the globe.
